JP2013056928A5 - - Google Patents

Download PDF

Info

Publication number
JP2013056928A5
JP2013056928A5 JP2012256454A JP2012256454A JP2013056928A5 JP 2013056928 A5 JP2013056928 A5 JP 2013056928A5 JP 2012256454 A JP2012256454 A JP 2012256454A JP 2012256454 A JP2012256454 A JP 2012256454A JP 2013056928 A5 JP2013056928 A5 JP 2013056928A5
Authority
JP
Japan
Prior art keywords
fentanyl
formulation
propellant
sublingual formulation
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012256454A
Other languages
English (en)
Japanese (ja)
Other versions
JP5630877B2 (ja
JP2013056928A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013056928A publication Critical patent/JP2013056928A/ja
Publication of JP2013056928A5 publication Critical patent/JP2013056928A5/ja
Application granted granted Critical
Publication of JP5630877B2 publication Critical patent/JP5630877B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012256454A 2006-01-25 2012-11-22 舌下フェンタニルスプレー Active JP5630877B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76205706P 2006-01-25 2006-01-25
US60/762,057 2006-01-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008552436A Division JP5241514B2 (ja) 2006-01-25 2007-01-25 舌下フェンタニルスプレー

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013059447A Division JP2013127003A (ja) 2006-01-25 2013-03-22 舌下フェンタニルスプレー

Publications (3)

Publication Number Publication Date
JP2013056928A JP2013056928A (ja) 2013-03-28
JP2013056928A5 true JP2013056928A5 (https=) 2013-05-09
JP5630877B2 JP5630877B2 (ja) 2014-11-26

Family

ID=38309867

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008552436A Active JP5241514B2 (ja) 2006-01-25 2007-01-25 舌下フェンタニルスプレー
JP2012256454A Active JP5630877B2 (ja) 2006-01-25 2012-11-22 舌下フェンタニルスプレー
JP2013059447A Pending JP2013127003A (ja) 2006-01-25 2013-03-22 舌下フェンタニルスプレー

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008552436A Active JP5241514B2 (ja) 2006-01-25 2007-01-25 舌下フェンタニルスプレー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013059447A Pending JP2013127003A (ja) 2006-01-25 2013-03-22 舌下フェンタニルスプレー

Country Status (16)

Country Link
US (6) US8486972B2 (https=)
EP (2) EP2641595A1 (https=)
JP (3) JP5241514B2 (https=)
CN (1) CN101378735B (https=)
AU (1) AU2007208229B2 (https=)
BR (1) BRPI0707235B8 (https=)
CA (1) CA2637672C (https=)
DK (1) DK1976521T3 (https=)
ES (1) ES2535233T3 (https=)
MX (3) MX2008009522A (https=)
NZ (1) NZ569949A (https=)
PL (1) PL1976521T3 (https=)
PT (1) PT1976521E (https=)
RU (1) RU2432950C2 (https=)
SI (1) SI1976521T1 (https=)
WO (1) WO2007087431A2 (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4898073B2 (ja) 2000-07-31 2012-03-14 ニュコメデ ダンマルク アンパーツセルスカブ 鼻内投与用フェンタニル組成物
RU2432950C2 (ru) 2006-01-25 2011-11-10 Инсис Терапьютикс Инк. Подъязычный спрей на основе фентанила
US8210167B2 (en) * 2007-03-02 2012-07-03 Corbco, Inc. Manually operated monodose nasal sprayer
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
ES2668366T3 (es) * 2007-08-02 2018-05-17 Insys Development Company, Inc. Pulverización sublingual de fentanilo
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
EP3581169A1 (en) * 2008-01-22 2019-12-18 The Board Of Regents Of The University Of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
US20090286832A1 (en) * 2008-05-15 2009-11-19 Kiichiro Nabeta Narcotic emulsion formulations for treatment of surgical pain
EP2400838B1 (en) * 2009-02-26 2016-05-11 Teikoku Pharma USA, Inc. Narcotic emulsion formulations for treatment of cancer pain
GB2469792A (en) * 2009-04-23 2010-11-03 Calvin John Ross Oil-based pharmaceutical formulation for sublingual delivery
JP2012524771A (ja) * 2009-04-23 2012-10-18 ロンドンファーマ リミテッド 中性油を含む舌下用の医薬組成物
RU2572692C2 (ru) * 2009-05-15 2016-01-20 Рекро Фарма, Инк. Сублингвальные композиции дексмедетомидина и способы их применения
EP2470172A1 (en) * 2009-08-26 2012-07-04 Nuvo Research Inc. Pharmaceutical formulations and methods of use
US20130202654A1 (en) * 2009-11-23 2013-08-08 Cipla Limited Topical Foam Composition
WO2011073985A1 (en) * 2009-12-14 2011-06-23 Coeruleus Ltd. Compositions and methods of counteracting residual sedative effects of sleep/ hypnotic drugs
GB2483579A (en) * 2010-06-30 2012-03-14 Londonpharma Ltd Sublingual formulations comprising methadone and ethanol for use in reducing pain
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
GB2487007B (en) * 2012-03-19 2013-06-05 Londonpharma Ltd COC containers and delivery devices for the sublingual administration of opioids
US9918981B2 (en) 2013-09-10 2018-03-20 Insys Development Company, Inc. Liquid buprenorphine formulations
DK3043777T3 (da) 2013-09-10 2020-07-20 Fresh Cut Dev Llc Sublingual buprenorphinspray
US9839611B2 (en) 2013-09-10 2017-12-12 Insys Development Company, Inc. Sublingual buprenorphine spray
US9867818B2 (en) 2013-09-10 2018-01-16 Insys Development Company, Inc. Sublingual buprenorphine spray
US9956166B2 (en) 2013-09-18 2018-05-01 Sorrento Therapeutics, Inc. Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
JP2016540748A (ja) * 2013-11-14 2016-12-28 インシス・ファーマ・インコーポレーテッド オンダンセトロン舌下スプレー製剤
CA2954370A1 (en) * 2014-07-08 2016-01-14 Insys Pharma, Inc. Sublingual naloxone spray
US9855234B2 (en) * 2014-07-08 2018-01-02 Insys Development Company, Inc. Diclofenac sublingual spray
US11135155B2 (en) 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US10441538B2 (en) * 2014-07-08 2019-10-15 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US10722510B2 (en) * 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US20160199294A1 (en) * 2014-07-08 2016-07-14 Insys Development Company, Inc. Sublingual naloxone spray
US10617686B2 (en) * 2014-07-08 2020-04-14 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone
US10172833B2 (en) 2015-08-11 2019-01-08 Insys Development Company, Inc. Sublingual ondansetron spray
US20170296506A1 (en) * 2016-04-13 2017-10-19 Board Of Regents Of The University Of Nebraska Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
WO2017205710A1 (en) * 2016-05-27 2017-11-30 Insys Development Company, Inc. Sublingual fentanyl formulations containing a permeation enhancer
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using
CA3166250A1 (en) * 2020-02-05 2021-08-12 Gregory G. Plucinski Drug products for intranasal administration and uses thereof
CN119265041A (zh) * 2020-05-19 2025-01-07 瓦克萨科技有限公司 用于治疗细胞因子风暴综合征的光合控制的螺旋藻提取物
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244478A (en) * 1979-06-27 1981-01-13 Mpl, Inc. Closure assembly for unit dose vial
GB8900267D0 (en) 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
US5219083A (en) * 1992-04-02 1993-06-15 Sterling Winthrop Inc. Stopper for reduction of particulate matter
DE69414710T2 (de) * 1993-08-10 1999-04-08 The Boots Co., Plc, Nottingham, Nottinghamshire Spruehformulierung mit kuehleffekt
ATE223202T1 (de) * 1994-09-30 2002-09-15 Mika Pharma Ges Fuer Die Entwi Pharmazeutische zusammensetzung
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
AU4894697A (en) * 1997-10-01 1999-04-23 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20090162300A1 (en) * 1997-10-01 2009-06-25 Dugger Iii Harry A Buccal, polar and non-polar spray containing alprazolam
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
US7087215B2 (en) * 1998-12-21 2006-08-08 Generex Pharmaceuticals Incorporated Methods of administering and enhancing absorption of pharmaceutical agents
AU2879100A (en) * 1999-02-12 2000-08-29 Miles A. Libbey Iii Formulation and system for intra-oral delivery of pharmaceutical agents
US20030190290A1 (en) * 2000-06-22 2003-10-09 Calvin Ross Pharmaceutical compositions
US20020160991A1 (en) * 2000-12-04 2002-10-31 Liming Shao Orally-bioavailable formulations of fentanyl and congeners thereof
US20040092428A1 (en) * 2001-11-27 2004-05-13 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
US6946150B2 (en) 2002-08-14 2005-09-20 Gw Pharma Limited Pharmaceutical formulation
CN1777411B (zh) * 2003-02-24 2013-01-02 药品生产公司 经粘膜药物递送系统
GB0305579D0 (en) * 2003-03-11 2003-04-16 Dallas Burston Ltd Pharmaceutical compositions
US20060062812A1 (en) * 2003-03-11 2006-03-23 Calvin Ross Novel compositions
KR20050115276A (ko) * 2003-03-11 2005-12-07 아라키스 리미티드 신규한 조성물
GB0514043D0 (en) 2005-07-08 2005-08-17 Arakis Ltd Fentanyl formulation
US20070124554A1 (en) * 2005-10-28 2007-05-31 Honeywell International Inc. Global memory for a rapidio network
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
RU2432950C2 (ru) 2006-01-25 2011-11-10 Инсис Терапьютикс Инк. Подъязычный спрей на основе фентанила
ES2668366T3 (es) 2007-08-02 2018-05-17 Insys Development Company, Inc. Pulverización sublingual de fentanilo

Similar Documents

Publication Publication Date Title
JP2013056928A5 (https=)
RU2432950C2 (ru) Подъязычный спрей на основе фентанила
PE20091672A1 (es) Nueva dosificacion y formulacion
WO2013155201A3 (en) Spray ejector mechanisms and devices providing charge isolation and controllable droplet charge, and low dosage volume opthalmic administration
EA201692388A1 (ru) Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
JP2007106777A5 (https=)
UA107499C2 (uk) Склад сухого порошку, який містить антимускариновий засіб
FI3435996T3 (fi) Elafibranori käytettäväksi primaarisen biliaarisen kolangiitin hoidossa
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
JP2015078230A5 (https=)
JP2016534142A5 (https=)
IL292465B1 (en) Neuroactive compounds and methods of using them
HRP20140582T1 (hr) Kombinacijska terapija za copd
JP2012162557A5 (https=)
WO2013019058A3 (en) Pharmaceutical composition for inhibiting cancer recurrence or metastasis
RU2015124694A (ru) Саморегулируемое высвобождение фармацевтического ингредиента
JP2016501828A5 (https=)
JP2014129360A5 (https=)
WO2013090278A3 (en) Intranasal dexmedetomidine compositions and methods of use thereof
JP2014218522A5 (https=)
HRP20140550T1 (hr) Aerosolna formulacija za copd
JP2010527347A5 (https=)
JP2015505541A5 (https=)
RU2016132762A (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
MX2017004476A (es) Composicion que comprende al menos un polvo seco obtenido por secado por atomizacion para aumentar la estabilidad de la formulacion.